{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:09:39Z","timestamp":1792004979029,"version":"4.4.0"},"reference-count":24,"publisher":"European Respiratory Society (ERS)","issue":"1","license":[{"start":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T00:00:00Z","timestamp":1571184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.ersjournals.com\/user-licence"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2019,10,5]]},"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1183\/13993003.01333-2019","type":"journal-article","created":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T04:24:18Z","timestamp":1571286258000},"page":"1901333","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":86,"title":["Anti-IL5 and anti-IL5R\u03b1 therapy for clinically significant bronchiectasis with eosinophilic endotype: a case series"],"prefix":"10.1183","volume":"55","author":[{"given":"Jessica","family":"Rademacher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Konwert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2926-3608","authenticated-orcid":false,"given":"Jan","family":"Fuge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Dettmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Welte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9084-4968","authenticated-orcid":false,"given":"Felix C.","family":"Ringshausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2019,10,16]]},"reference":[{"key":"2024102101133940000_55.1.1901333.1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00119114"},{"key":"2024102101133940000_55.1.1901333.2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cyto.2017.08.005","article-title":"The role of non-invasive modalities for assessing inflammation in patients with non-cystic fibrosis bronchiectasis","volume":"99","author":"Tsikrika","year":"2017","journal-title":"Cytokine"},{"key":"2024102101133940000_55.1.1901333.3","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.congress-2018.PA2665"},{"key":"2024102101133940000_55.1.1901333.4","doi-asserted-by":"publisher","DOI":"10.1097\/ACI.0000000000000251"},{"key":"2024102101133940000_55.1.1901333.5","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S2213-2600(16)30031-5","article-title":"Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies","volume":"4","author":"Ortega","year":"2016","journal-title":"Lancet Respir Med"},{"key":"2024102101133940000_55.1.1901333.6","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S2213-2600(17)30125-X","article-title":"Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial","volume":"5","author":"Chupp","year":"2017","journal-title":"Lancet Respir Med"},{"key":"2024102101133940000_55.1.1901333.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1403291"},{"key":"2024102101133940000_55.1.1901333.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0808991"},{"key":"2024102101133940000_55.1.1901333.9","first-page":"681","article-title":"Mepolizumab for eosinophilic COPD","volume":"378","author":"Sciurba","year":"2018","journal-title":"N Engl J Med"},{"key":"2024102101133940000_55.1.1901333.10","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1056\/NEJMoa1708208","article-title":"Mepolizumab for eosinophilic chronic obstructive pulmonary disease","volume":"377","author":"Pavord","year":"2017","journal-title":"N Engl J Med"},{"key":"2024102101133940000_55.1.1901333.11","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(16)31322-8","article-title":"Benralizumab, an anti-interleukin-5 receptor \u03b1 monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"388","author":"FitzGerald","year":"2016","journal-title":"Lancet"},{"key":"2024102101133940000_55.1.1901333.12","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1056\/NEJMoa1905248","article-title":"Benralizumab for the prevention of COPD exacerbations","volume":"381","author":"Criner","year":"2019","journal-title":"N Engl J Med"},{"key":"2024102101133940000_55.1.1901333.13","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2466-13-11"},{"key":"2024102101133940000_55.1.1901333.14","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2147\/JAA.S196200","article-title":"Severe uncontrolled asthma with bronchiectasis: a pilot study of an emerging phenotype that responds to mepolizumab","volume":"12","author":"Carpagnano","year":"2019","journal-title":"J Asthma Allergy"},{"key":"2024102101133940000_55.1.1901333.15","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00629-2017"},{"key":"2024102101133940000_55.1.1901333.16","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2018-000348"},{"key":"2024102101133940000_55.1.1901333.17","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780330806"},{"key":"2024102101133940000_55.1.1901333.18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s12890-018-0689-2","article-title":"Anti-IL-5 therapy in patients with severe eosinophilic asthma \u2013 clinical efficacy and possible criteria for treatment response","volume":"18","author":"Drick","year":"2018","journal-title":"BMC Pulm Med"},{"key":"2024102101133940000_55.1.1901333.19","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0140-6736(16)31324-1","article-title":"Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting \u03b22-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial","volume":"388","author":"Bleecker","year":"2016","journal-title":"Lancet"},{"key":"2024102101133940000_55.1.1901333.20","doi-asserted-by":"publisher","DOI":"10.1111\/crj.12198"},{"key":"2024102101133940000_55.1.1901333.21","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01269-2018"},{"key":"2024102101133940000_55.1.1901333.22","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02052-2017"},{"key":"2024102101133940000_55.1.1901333.23","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02053-2017"},{"key":"2024102101133940000_55.1.1901333.24","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S2213-2600(18)30053-5","article-title":"Bronchiectasis: new therapies and new perspectives","volume":"6","author":"Chalmers","year":"2018","journal-title":"Lancet Respir Med"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.01333-2019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T07:24:33Z","timestamp":1740381873000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.01333-2019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,16]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1,23]]},"published-print":{"date-parts":[[2020,1]]}},"alternative-id":["10.1183\/13993003.01333-2019"],"URL":"https:\/\/doi.org\/10.1183\/13993003.01333-2019","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,16]]}}}